Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

被引：0
作者：
O. Katopodis
J. Souglakos
E. Stathopoulos
A. Christopoulou
E. Kontopodis
A. Kotsakis
K. Kalbakis
N. Kentepozidis
A. Polyzos
D. Hatzidaki
V. Georgoulias
机构：
[1] Hellenic Oncology Research Group (HORG),
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Gemcitabine; Oxaliplatin; Erlotinib; Phase II trial; Pancreas;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 340
页数：7
相关论文
共 55 条
[21]  
Stocken DD(undefined)undefined undefined undefined undefined-undefined
[22]  
Heinemann V(undefined)undefined undefined undefined undefined-undefined
[23]  
Boeck S(undefined)undefined undefined undefined undefined-undefined
[24]  
Hinke A(undefined)undefined undefined undefined undefined-undefined
[25]  
Poplin E(undefined)undefined undefined undefined undefined-undefined
[26]  
Feng Y(undefined)undefined undefined undefined undefined-undefined
[27]  
Berlin J(undefined)undefined undefined undefined undefined-undefined
[28]  
Louvet C(undefined)undefined undefined undefined undefined-undefined
[29]  
Labianca R(undefined)undefined undefined undefined undefined-undefined
[30]  
Hammel P(undefined)undefined undefined undefined undefined-undefined
123456